A multicenter randomized trial that will compare the effectiveness of two postpartum blood pressure (BP) management strategies in improving blood pressure and cardiac function and increasing patient engagement and feeling of control over one's health
Age ≥18 years
Delivery within 14 days
Diagnosis of preeclampsia or gestational hypertension with or without severe features during pregnancy or within 14 days postpartum
Initiation of blood pressure medication prior to hospital discharge and up to 14 days postpartum
Diagnosis of chronic hypertension prior to delivery (would therefore include super imposed preeclampsia)
Pre-existing cardiovascular disease (including prior myocardial infarction, stroke, heart failure with reduced ejection fraction, ventricular tachycardia, prior cardiac arrest, pacemaker, severe valvular heart disease, or prior cardiac surgery)
Chronic kidney disease (stage 3 or higher)
Using ≥3 BP medications at time of enrollment
Jennifer Lewey, MD, MPH
Lead sponsor
University of Pennsylvania
Sponsor institution
Patient-Centered Outcomes Research Institute
Collaborator